{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:18:41Z","timestamp":1789586321275,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,2]],"date-time":"2015-11-02T00:00:00Z","timestamp":1446422400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["DK-MCD W1226"],"award-info":[{"award-number":["DK-MCD W1226"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["SFB-LIPOTOX F3004"],"award-info":[{"award-number":["SFB-LIPOTOX F3004"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P22832"],"award-info":[{"award-number":["P22832"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P27070"],"award-info":[{"award-number":["P27070"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P25193"],"award-info":[{"award-number":["P25193"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medical University of Graz","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.atherosclerosis.2015.10.109","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T20:17:02Z","timestamp":1446668222000},"page":"9-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice"],"prefix":"10.1016","volume":"244","author":[{"given":"Nemanja","family":"Vujic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Schlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas O.","family":"Eichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina T.","family":"Madreiter-Sokolowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Goeritzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Rosenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Woelfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Doddapattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Hoefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Lass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang F.","family":"Graier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislav","family":"Radovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-7573","authenticated-orcid":false,"given":"Dagmar","family":"Kratky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib1","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2011.12.018","article-title":"FAT SIGNALS\u2013lipases and lipolysis in lipid metabolism and signaling","volume":"15","author":"Zechner","year":"2012","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib2","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0022-2275(20)40184-1","article-title":"Rat adipose tissue lipases: hormone-sensitive lipase activity against triglycerides compared with activity against lower glycerides","volume":"5","author":"Strand","year":"1964","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0014-5793(97)01603-7","article-title":"Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand","volume":"422","author":"Goparaju","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.chembiol.2007.11.006","article-title":"A\u00a0comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol","volume":"14","author":"Blankman","year":"2007","journal-title":"Chem. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib5","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.bjp.0704297","article-title":"Despite substantial degradation, 2-arachidonoylglycerol is a potent full efficacy agonist mediating CB(1) receptor-dependent G-protein activation in rat cerebellar membranes","volume":"134","author":"Savinainen","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0026-895X(24)26516-0","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide","volume":"57","author":"Gonsiorek","year":"2000","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0091-3057(01)00694-3","article-title":"Reversal of delta 9-THC hyperphagia by SR141716 and naloxone but not dexfenfluramine","volume":"71","author":"Williams","year":"2002","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib8","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI200523057","article-title":"Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity","volume":"115","author":"Osei-Hyiaman","year":"2005","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib9","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1172\/JCI34827","article-title":"Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice","volume":"118","author":"Osei-Hyiaman","year":"2008","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00395-010-0090-7","article-title":"CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function","volume":"105","author":"Tiyerili","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/ATVBAHA.108.168757","article-title":"Rimonabant, a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice","volume":"29","author":"Dol-Gleizes","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib12","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/jpet.106.108381","article-title":"Cannabinoid treatment suppresses the T-helper cell-polarizing function of mouse dendritic cells stimulated with Legionella pneumophila infection","volume":"319","author":"Lu","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-2999(00)00211-9","article-title":"Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB(2) receptor","volume":"396","author":"Buckley","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-5728(00)00307-6","article-title":"In\u00a0vivo and in\u00a0vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in\u00a0vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors","volume":"109","author":"Sacerdote","year":"2000","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib15","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0167-5699(98)01300-0","article-title":"Cannabinoid receptors and immunity","volume":"19","author":"Klein","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1124\/jpet.102.033506","article-title":"Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in\u00a0vitro and in\u00a0vivo","volume":"302","author":"McKallip","year":"2002","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/S0022-3565(24)37693-1","article-title":"Delta9-tetrahydrocannabinol induces apoptosis in macrophages and lymphocytes: involvement of Bcl-2 and caspase-1","volume":"286","author":"Zhu","year":"1998","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1874192401105010015","article-title":"Cannabinoid receptor 2 deficiency in haematopoietic cells aggravates early atherosclerosis in LDL receptor deficient mice","volume":"5","author":"Delsing","year":"2011","journal-title":"Open Cardiovasc. Med. J."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib20","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.yjmcc.2011.08.008","article-title":"Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in\u00a0vivo","volume":"51","author":"Hoyer","year":"2011","journal-title":"J.\u00a0Mol. Cell Cardiol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejphar.2010.09.027","article-title":"WIN55212-2 ameliorates atherosclerosis associated with suppression of pro-inflammatory responses in ApoE-knockout mice","volume":"649","author":"Zhao","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib22","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.atherosclerosis.2008.12.040","article-title":"Regulation and possible role of endocannabinoids and related mediators in hypercholesterolemic mice with atherosclerosis","volume":"205","author":"Montecucco","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0021-9258(18)51692-6","article-title":"Hormone-sensitive lipase and monoglyceride lipase activities in adipose tissue","volume":"239","author":"Vaughan","year":"1964","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib24","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1124\/mol.110.068304","article-title":"Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system","volume":"78","author":"Chanda","year":"2010","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib26","doi-asserted-by":"crossref","first-page":"17467","DOI":"10.1074\/jbc.M110.215434","article-title":"Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance","volume":"286","author":"Taschler","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib27","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jchromb.2014.01.011","article-title":"A\u00a0versatile ultra-high performance LC-MS method for lipid profiling","volume":"951\u2013952","author":"Knittelfelder","year":"2014","journal-title":"J.\u00a0Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib28","doi-asserted-by":"crossref","first-page":"28444","DOI":"10.1074\/jbc.M111.244517","article-title":"Leucine zipper EF hand-containing transmembrane protein 1 (Letm1) and uncoupling proteins 2 and 3 (UCP2\/3) contribute to two distinct mitochondrial Ca2+ uptake pathways","volume":"286","author":"Waldeck-Weiermair","year":"2011","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib29","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1194\/jlr.M052613","article-title":"Deletion of CGI-58 or adipose triglyceride lipase differently affects macrophage function and atherosclerosis","volume":"55","author":"Goeritzer","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib30","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1194\/jlr.M800376-JLR200","article-title":"Synthetic LXR agonist attenuates plaque formation in apoE-\/- mice without inducing liver steatosis and hypertriglyceridemia","volume":"50","author":"Kratzer","year":"2009","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib31","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.ajpath.2011.05.020","article-title":"Stage-specific remodeling of atherosclerotic lesions upon cholesterol lowering in LDL receptor knockout mice","volume":"179","author":"Zhao","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib32","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1124\/mol.110.069427","article-title":"Endocannabinoid overload","volume":"78","author":"Lichtman","year":"2010","journal-title":"Mol. Pharmacol."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.atherosclerosis.2015.10.109_bib33","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1111\/j.1537-2995.2011.03368.x","article-title":"Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system","volume":"51","author":"Jiang","year":"2011","journal-title":"Transfusion"},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib34","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2013.12.042","article-title":"Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor","volume":"233","author":"Chiurchiu","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib35","doi-asserted-by":"crossref","first-page":"23807","DOI":"10.1074\/jbc.M002087200","article-title":"Free cholesterol loading of macrophages induces apoptosis involving the fas pathway","volume":"275","author":"Yao","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib36","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1189\/jlb.0209115","article-title":"Mechanisms and consequences of efferocytosis in advanced atherosclerosis","volume":"86","author":"Thorp","year":"2009","journal-title":"J.\u00a0Leukoc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib37","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1161\/ATVBAHA.108.179739","article-title":"Concept of vulnerable\/unstable plaque","volume":"30","author":"Finn","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib38","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11883-014-0401-9","article-title":"Pathophysiology of acute coronary syndrome","volume":"16","author":"Santos-Gallego","year":"2014","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib40","doi-asserted-by":"crossref","first-page":"9902","DOI":"10.1074\/jbc.271.17.9902","article-title":"(-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase","volume":"271","author":"Bayewitch","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.plipres.2006.03.003","article-title":"Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand","volume":"45","author":"Sugiura","year":"2006","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/sj.bjp.0707523","article-title":"CB2 receptor-mediated migration of immune cells: it can go either way","volume":"153","author":"Miller","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/ATVBAHA.112.300275","article-title":"Fatty acid amide hydrolase deficiency enhances intraplaque neutrophil recruitment in atherosclerotic mice","volume":"33","author":"Lenglet","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib44","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1074\/jbc.274.5.2794","article-title":"Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds","volume":"274","author":"Sugiura","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1074\/jbc.275.1.605","article-title":"Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells","volume":"275","author":"Sugiura","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2015.10.109_bib46","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tips.2012.03.002","article-title":"At the heart of the matter: the endocannabinoid system in cardiovascular function and dysfunction","volume":"33","author":"Montecucco","year":"2012","journal-title":"Trends Pharmacol. Sci."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015301933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915015301933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T09:08:34Z","timestamp":1748682514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915015301933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":46,"alternative-id":["S0021915015301933"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.10.109","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.10.109","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}